Related Party Transactions (Details Narrative) - USD ($) |
1 Months Ended | 12 Months Ended | ||||
|---|---|---|---|---|---|---|
Mar. 31, 2025 |
Aug. 31, 2024 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Jul. 31, 2025 |
Jul. 31, 2024 |
|
| Related Party [Member] | ||||||
| Other liabilities | $ 147,120 | $ 3,947 | ||||
| Titan Pharmaceuticals Inc [Member] | ||||||
| Proceeds from promissory note | $ 500,000 | |||||
| Payments of fees | $ 9,000 | $ 13,000 | ||||
| Advances | 62,000 | |||||
| Titan Pharmaceuticals Inc [Member] | TALENTEC SDN. BHD. [Member] | ||||||
| Payable balance | 2,466,000 | |||||
| Titan Pharmaceuticals Inc [Member] | Black Titan [Member] | ||||||
| Receivables, net | 3,217,000 | $ 62,000 | ||||
| Advances | $ 3,155,000 | |||||
| Titan Pharmaceuticals Inc [Member] | Lazar Promissory Note [Member] | ||||||
| Conversion of stock, amount converted | $ 4,511,000 | |||||
| Conversion of stock, shares converted | 54,132 | |||||
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cash outflow for fees classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cash received from principal payments made on loans related to operating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|